KDM4 Involvement in Breast Cancer and Possible Therapeutic Approaches
Breast cancer (BC) is the second leading cause of cancer death in women, although recent scientific and technological achievements have led to significant improvements in progression-free disease and overall survival of patients. Genetic mutations and epigenetic modifications play a critical role in...
Main Authors: | Benluvankar Varghese, Nunzio Del Gaudio, Gilda Cobellis, Lucia Altucci, Angela Nebbioso |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-10-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2021.750315/full |
Similar Items
-
Small molecule KDM4s inhibitors as anti-cancer agents
by: Hongzhi Lin, et al.
Published: (2018-01-01) -
Identification and characterization of PKF118-310 as a KDM4A inhibitor
by: Gianluigi Franci, et al.
Published: (2017-03-01) -
Role for the Histone Demethylase KDM4B in Rhabdomyosarcoma via CDK6 and CCNA2: Compensation by KDM4A and Apoptotic Response of Targeting Both KDM4B and KDM4A
by: Zoë S. Walters, et al.
Published: (2021-04-01) -
Functions and Interactions of Mammalian KDM5 Demethylases
by: Egor Pavlenko, et al.
Published: (2022-07-01) -
The Emerging Significance of Histone Lysine Demethylases as Prognostic Markers and Therapeutic Targets in Head and Neck Cancers
by: Dawid Dorna, et al.
Published: (2022-03-01)